Literature DB >> 22863527

C-N bond formation under Cu-catalysis: synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase.

Raju Adepu1, K Shiva Kumar, Sandhya Sandra, D Rambabu, G Rama Krishna, C Malla Reddy, Ajit Kandale, Parimal Misra, Manojit Pal.   

Abstract

A series of novel N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones were designed and synthesized as potential inhibitors of chorismate mutase. Synthesis of this class of compounds was carried out by using Cu-mediated C-N bond forming reaction between thieno[2,3-d]pyrimidin-4(3H)-ones and aryl boronic acids. The reaction can be performed in an open flask as the conversion was found to be not sensitive to the presence of air or atmospheric moisture. A range of compounds were prepared by using this method and single crystal X-ray diffraction study was performed using a representative compound. In vitro pharmacological data of some of the compounds synthesized along with dose response studies using active molecules are presented. In silico interactions of these molecules with chorismate mutase are also presented.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863527     DOI: 10.1016/j.bmc.2012.07.011

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes.

Authors:  Martin Krátký; Eva Novotná; Shalini Saxena; Perumal Yogeeswari; Dharmarajan Sriram; Markéta Švarcová; Jarmila Vinšová
Journal:  ScientificWorldJournal       Date:  2014-11-04

2.  Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides.

Authors:  Snehlata Yadav; Siong Meng Lim; Kalavathy Ramasamy; Mani Vasudevan; Syed Adnan Ali Shah; Abhishek Mathur; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-05-26       Impact factor: 4.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.